PAUL A FINCH, LCSW
Social Work in Bethesda, MD
License number
Maryland 0904004853
Category
Social Work
Type
Clinical
Address
Address
2
8901 Wisconsin Ave Social DEPARTMENT WORK, Bethesda, MD 20889
2300 NW Bldg 6 ROOM 6100, Washington, DC 20372
2300 NW Bldg 6 ROOM 6100, Washington, DC 20372
Phone
(301) 295-1719
(202) 762-3101
(202) 762-1626 (Fax)
(202) 762-3101
(202) 762-1626 (Fax)
Professional information
Paul A Finch, Bethesda MD - LCSW
Specialties:
Social Work, Clinical Social Work
Address:
8901 Wisconsin Ave, Bethesda 20889
(301) 295-1719 (Phone)
(301) 295-1719 (Phone)
Languages:
English
Dna Encoding A Growth Factor Specific For Epithelial Cells
US Patent:
6709842, Mar 23, 2004
Filed:
Jun 7, 1995
Appl. No.:
08/477982
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C12N 121
US Classification:
435 694, 435 697, 435 711, 435358, 435365, 4352523, 4352528, 4352542, 4353201, 536 234, 536 2551, 530399
Abstract:
Disccoveries are disclosed that show particular aspects of recombinant DNA technology can be used sucessfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Epithelial Cell Specific Growth Factor, Keratinocyte Growth Factor (Kgf)
US Patent:
6420531, Jul 16, 2002
Filed:
May 31, 1995
Appl. No.:
08/455620
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States as represented by the Department of Health and Human Services - Washington DC
International Classification:
C07K 14475
US Classification:
530399, 530395, 930 10, 435 694, 435243, 435325
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used sucessfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Method Of Stimulating Epithelial Cells Using Keratinocyte Growth Factor (Kgf) And Method Of Inhibiting Kgf Activity
US Patent:
6833132, Dec 21, 2004
Filed:
May 31, 1995
Appl. No.:
08/455975
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services - Washington DC
International Classification:
A61K 3818
US Classification:
4241451, 4241391, 4241411, 514 2, 514 12, 514 21, 530399, 5303871, 5303879, 5303881, 53038824
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used sucessfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Assay For Detecting The Expression Of A Gene Encoding Human Keratinocyte Growth Factor (Kgf)
US Patent:
5741642, Apr 21, 1998
Filed:
May 31, 1995
Appl. No.:
8/455672
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C12Q 168, C12P 1934, C07H 2102, C07H 2104
US Classification:
435 6
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Antbodies To Human Kerctinocyte Growth Factor (Kgf) And Related Pharmaceuticals
US Patent:
5654405, Aug 5, 1997
Filed:
May 31, 1995
Appl. No.:
8/455655
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C07K 1622, A61K 39395, C12N 512
US Classification:
5303879
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Dna Encoding A Growth Factor Specific For Epithelial Cells
US Patent:
5731170, Mar 24, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/480948
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C12N 121, C12N 510, C12N 1511, C12N 1518
US Classification:
435 694
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments. introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Assay For Detecting Keratinocyte Growth Factor (Kgf) And Its Activity
US Patent:
5707805, Jan 13, 1998
Filed:
May 31, 1995
Appl. No.:
8/455641
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C12Q 168, G01N 3353
US Classification:
435 6
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.
Method Of Purifying Keratinocyte Growth Factor (Kgf)
US Patent:
5665870, Sep 9, 1997
Filed:
May 31, 1995
Appl. No.:
8/455628
Inventors:
Jeffrey S. Rubin - Rockville MD
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Paul W. Finch - Bethesda MD
Stuart A. Aaronson - Great Falls VA
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
C07K 114, C07K 1450, C07K 116, C07K 118
US Classification:
530412
Abstract:
Discoveries are disclosed that show particular aspects of recombinant DNA technology can be used successfully to produce hitherto unknown human keratinocyte growth factor (KGF) protein free of other polypeptides. These proteins can be produced in various functional forms from spontaneously secreting cells or from DNA segments introduced into cells. These forms variously enable biochemical and functional studies of this novel protein as well as production of antibodies. Means are described for determining the level of expression of genes for the KGF protein, for example, by measuring mRNA levels in cells or by measuring antigen secreted in extracellular or body fluids.